IBA

3, chemin du Cyclotron
Louvain-La-Neuve, USA 1348
Belgium
Phone: 3210475811
[email protected]
Visit Website

RELATED CONTENT

By combining the portfolios of both companies, IBA Dosimetry and ScandiDos can accomplish this vision, offering an increasingly extensive suite of products that provide a consistent solution for all aspects of radiotherapy quality assurance.
News | Radiation Therapy

IBA and ScandiDos Form Strategic Alliance to Increase Access to Safe ...

September 1, 2022 —   IBA S.A., a leader in particle accelerator technology and a leader in dosimetry quality assurance ...

Time September 01, 2022
Read more
Ms Preetha Reddy (Executive Vice Chairman AHEL), Dr Prathap Reddy (Chairman AHEL), Olivier Legrain (CEO IBA) & Dr Rakesh Jalali (Clinical Director APCC)
News | Proton Therapy

IBA and Apollo Proton Cancer Centre Sign a Collaboration Agreement to ...

August 19, 2022 —  IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time August 19, 2022
Read more
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News | Proton Therapy

IBA, Fred Hutchinson Cancer Center and the University of Washington ...

August 5, 2022 —  IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
Read more
The ConformalFLASH Alliance will be the first collaboration platform between academia and industry to bring ConformalFLASH proton therapy to the clinic
News | Proton Therapy

IBA launches the ConformalFLASH Alliance

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

Time July 01, 2022
Read more
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has received an order from CGN Medical Technologies for a Proteus PLUS[1] proton therapy system to be installed in Yangzhou, China
News | Proton Therapy

IBA Receives Order from CGNNT for a Proteus PLUS System to be ...

May 5, 2022 —  IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time May 05, 2022
Read more
IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry quality assurance solutions, today announces it has acquired Modus Medical Devices Inc. (Modus QA), a Canadian company based in London, Ontario, specialized in phantoms for quality assurance for radiation therapy.
News | Radiology Business

IBA Strengthens its Dosimetry Portfolio with Acquisition of Modus ...

May 3, 2022 — IBA (Ion Beam Applications S.A.), a leader in particle accelerator technology and the leader in dosimetry ...

Time May 03, 2022
Read more
IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, and the University Medical Center Groningen (UMCG) announce today a four-year research collaboration agreement towards development of a new FLASH irradiation protocol for the treatment of early-stage breast cancer.
News | Women's Health

IBA and UMC Groningen Engage in FLASH Irradiation Research ...

April 5, 2022 —  IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, and the University ...

Time April 05, 2022
Read more
IBA, a world leader in particle accelerator technology and the leading provider of radiopharmaceuticals production solutions, announced that it has launched a new low energy and compact size cyclotron, the Cyclone KEY.
News | Nuclear Imaging

IBA Launches Compact Low-Energy Cyclotron, Cyclone KEY

January 26, 2022 — IBA, a world leader in particle accelerator technology and the leading provider of ...

Time January 26, 2022
Read more
IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the opening of its INDux training center to maximize talent, share experiences and optimize knowledge of both customers and employees at its headquarters in Louvain-La-Neuve, Belgium.
News | Radiation Oncology

IBA Launches INDux Training Center to Optimize Customer Performance

December 30, 2021 — IBA (Ion Beam Applications S.A), a world leader in particle accelerator technology, announced the ...

Time December 30, 2021
Read more
 IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a contract for the installation of a Proteus ONE proton therapy solution with the New Mexico Cancer Center in Albuquerque, NM, USA.
News | Proton Therapy

IBA and New Mexico Cancer Center Sign Contract to Install a Proteus ...

December 22, 2021 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology and the world’s ...

Time December 22, 2021
Read more
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now